FIND A COMMITTEE
Use the drop downs below to find the roster and charter information for any IPO Committee.
To find the committee members or charter of a given committee, select a division and then the name of the committee. If you do not know the name of the division, simply click on the “Select Committee” button and all committees will be listed.
Pharmaceutical & Biotechnology Issues Committee
The committee will advise the IPO Board of Directors regarding legislative changes, patent office policies, regulatory issues and judicial decisions affecting the pharmaceutical and biotechnology industry, both in the U.S. and internationally. This includes pharmaceuticals and biologics subject to the Drug Price Competition and Patent Term Restoration Act (the Hatch-Waxman Act), the Biologics Price Competition and Innovation Act (the BPCIA Act), and counterpart laws and regulations in the U.S. and other jurisdictions. The Committee’s primary goal is to review proposed legislative and regulatory initiatives, and proactively submit comments and recommendations to the Board that reflect the proper balance between generic drug/biosimilar entry and maintaining strong incentives for the innovation development, and protection of new pharmaceutical products. A secondary goal of the committee is to monitor and comment upon judicial decisions and proposed patent practice changes for the education and benefit of IPO members.
Chair:Raymond Doss, Amgen, Inc.
Chair:Daniela Gill-Carey, Astellas Pharma Europe Ltd
Chair:J Jason Galvez, Johnson & Johnson
Vice Chair:Adrian Trioli, Adrian M Trioli - Intellectual Property
Vice Chair:Mercedes K. Meyer, Banner & Witcoff, Ltd.
Secretary:David Hammond, Haseltine Lake Kempner LLP
Board Liaison:Jamie Davis, Bayer Intellectual Property GmbH
Members
- Yoko AkizawaTakeda Pharmaceutical Company Limited
- Simon BradburyWithers & Rogers LLP
- Michael H. Brodowski, Ph.D.Cantor Colburn LLP
- Jennifer Robichaux CarterBaker Botts LLP
- Luiza CotiaRNA Law
- Denise DeFrancoJohnson & Johnson
- Evan DiamondMintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Matthew FletcherAbel & Imray
- Michael L. FullerKnobbe Martens
- David A. GassMarshall, Gerstein & Borun LLP
- Paul GolianBristol Myers Squibb Company
- Elsa B. GonzalezOlarteMoure & Asociados
- Eric GreenwaldMerck & Co Inc.
- Philippa GriffinMathys & Squire LLP
- Felicity E. GrothBakerHostetler
- Robert Joseph HiltonKnobbe Martens
- Erica HinesHeslin Rothenberg Farley & Mesiti PC
- Lisa HorningerJohnson & Johnson
- Loren HulseHolland & Hart LLP
- Ronald KernBakerHostetler
- Yu-An KOTai E International Patent & Law Office
- Julie M. LakeMerck & Co Inc.
- Wan Chieh (Jenny) LeeHaug Partners LLP
- Scott MacdonaldWilson Gunn
- Matthew L. MadsenOsha Bergman Watanabe & Burton LLP
- Mira MulvaneyEli Lilly and Co.
- Alycia NoeTyr LLP
- Kimberly J. PriorJohnson & Johnson
- Robert T. RamosProcopio, Cory, Hargreaves & Savitch LLP
- Teresa RegulyTorys LLP
- Henrietta RooneyElkington & Fife LLP
- Teige SheehanHeslin Rothenberg Farley & Mesiti PC
- Daniel L. ShoresRothwell, Figg, Ernst & Manbeck
- Kitt SindenAird & McBurney LP
- Andrew SkodynCassels Brock & Blackwell LLP
- Kaitlin Jane SoyeAird & McBurney LP
- Elizabeth N. SparAstellas Pharma Europe Ltd
- David SteinOlson Stein LLP
- Amrish TiwariK & S Partners
- Kathryn WadeKilpatrick Townsend & Stockton LLP
- Eleanor WilsonCassels Brock & Blackwell LLP
- Jay ZakaibGowling WLG (Canada) LLP
- Non-Voting Member:Andrea Lynn Evensen
- Non-Voting Member:Aloys Hüttermann, Michalski Hüttermann & Partner
- Non-Voting Member:Toby Mak, Tee & Howe Intellectual Property Attorneys
- Non-Voting Member:Andrew Shaughnessy, Torys LLP
- Non-Voting Member:Sarah Tully, Roche, Inc.